跳至主要内容
临床试验/CTRI/2020/05/025045
CTRI/2020/05/025045招募中1 期

Phase II study to assess safety & efficacy of using potentised (tautopathy) form of chemotherapy.

Central Council for Research in Homoeopathy0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1 Pre-diagnosed cases of cancer advised to undergo/undergoing chemotherapy with either cisplatin and/or Docetaxel.
  • 2 Any age group 18 years or above; willing to give written informed consent for participation.

排除标准

  • Patients having chemotherapy with drugs other than cisplatin and docetaxel.

研究者

发起方
Central Council for Research in Homoeopathy

相似试验